Market Research

AnxioFit-1 Demonstrates Anti-Anxiety Effects

August 6, 2012

In a human clinical study scientists found that AnxioFit-1, a product distributed by EuroPharma, Inc., Green Bay, WI under the Terry Naturally brand, has a significant effect on relieving anxiety within 3 days of use. AnxioFit-1 is a highly specialized extract of specific plant compounds from a single form of echinacea (angustifolia). Past research has suggested that AnxioFit-1 attaches to cannabinoid receptors in the brain to elicit a sense of calm and relaxation, without drowsiness. The study included 33 volunteers, 22 women and 11 men with an average age of 41. All experienced mild anxiety. Subjects used AnxioFit-1 for one week, and anxiety was evaluated before, during, and after using the product. A dose of two 20 mg tablets per day decreased STAI (both state and trait) scores within 3 days, an effect that remained stable for the duration of the treatment (7 days) and for the 2 weeks that followed treatment. There were no dropouts, demonstrating that the treatment was well tolerated. No adverse effects were recorded during the treatment period.
 

Related Market Segments:

  • Establishing Specifications as Required by Dietary Supplement cGMPs

    Establishing Specifications as Required by Dietary Supplement cGMPs

    Seong-Jae Yoo, PhD, & Gabriel Giancaspro, PhD, U.S. Pharmacopeial Convention (USP) ||March 1, 2017
    USP monographs can serve as useful resources to help dietary supplement manufacturers comply with federal standards.

  • Go for the Gold

    Go for the Gold

    Tom Branna, Editorial Director||March 1, 2017
    Consumers around the world are tuning in to turmeric’s health benefits.

  • Resources & Standards:  An Oven is Not a Cake Recipe

    Resources & Standards: An Oven is Not a Cake Recipe

    Steven Dentali, PhD, Botanical Industry Consultant||March 1, 2017
    Engaging with organizations that are leading validation efforts will help to build a stronger industry.